Literature DB >> 16110627

Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium.

S Pecorelli1, B Pasinetti, R Angioli, G Favalli, F Odicino.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16110627

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN: 0921-4410


× No keyword cloud information.
  6 in total

1.  microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

Authors:  Eric J Devor; Adriann M Hovey; Michael J Goodheart; Shyam Ramachandran; Kimberly K Leslie
Journal:  Oncol Rep       Date:  2011-07-01       Impact factor: 3.906

Review 2.  Hormonal replacement therapy in women with a history of internal genital organ malignancy.

Authors:  Maria Brzozowska; Andrzej Lewinski
Journal:  Prz Menopauzalny       Date:  2021-03-18

3.  Noncoding RNAs and Cancer.

Authors:  Mozhgan Moslemi Naeini; Ali M Ardekani
Journal:  Avicenna J Med Biotechnol       Date:  2009-07

Review 4.  Hormone replacement therapy for women previously treated for endometrial cancer.

Authors:  Katharine A Edey; Stuart Rundle; Martha Hickey
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15

5.  Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues.

Authors:  Taek Sang Lee; Hye Won Jeon; Yong Beom Kim; Young A Kim; Min A Kim; Soon Beom Kang
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

Review 6.  Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.

Authors:  Satoru Kyo; Kentaro Nakayama
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.